Adjuvant Radio-Chemotherapy with 5-Fluorouracil and Leucovorin in Stage II and III Rectal Cancer: 12 Months vs. 6 Months of Therapy. A Study of the Association for Medical Oncology of the German Cancer Society

Publisher： Karger

E-ISSN： 2296-5262|23|4|334-339

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.23, Iss.4, 2000-09, pp. : 334-339

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjuvant Radio-Chemotherapy in Stage II–III Rectal Cancer with 24-Hour Infusion of High-Dose 5-Fluorouracil and Folinic Acid: Evaluation of Feasibility

By  

Oncology Research and Treatment, Vol. 24, Iss. 5, 2001-10 ,pp. : 476-480

Karger

Access to resources Recommend Favorite

Adjuvant Chemotherapy in Stage III Colon Cancer with 5-Fluorouracil and Levamisole versus 5-Fluorouracil and Leucovorin

By  

Oncology Research and Treatment, Vol. 25, Iss. 5, 2002-11 ,pp. : 426-430

Karger

Access to resources Recommend Favorite

Phase II Study of Bolus 5-Fluorouracil and Leucovorin Combined with Weekly Paclitaxel as First-Line Therapy for Advanced Gastric Cancer

By  

Oncology, Vol. 81, Iss. 5-6, 2011-11 ,pp. : 291-297

Karger

Access to resources Recommend Favorite

Administration of adjuvant chemotherapy for stage II‐III colon cancer patients: An European population‐based study

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 7, 2018-04 ,pp. : 1480-1489

John Wiley & Sons Inc

Access to resources Recommend Favorite

Polymorphisms in folate‐metabolizing enzymes and response to 5‐fluorouracil among patients with stage II or III rectal cancer (INT‐0144; SWOG 9304)

By  

CANCER, Vol. 120, Iss. 21, 2014-11 ,pp. : 3329-3337

John Wiley & Sons Inc

Access to resources Recommend Favorite